A phase II trial of high-dose gemcitabine (GEM) plus cisplatin (CDDP) in advanced non small cell lung cancer(NSCLC).: Preliminary results.

被引：0
|
作者：
Isla, D [1 ]
Mayordom, JI [1 ]
Yubero, A [1 ]
Cajal, R [1 ]
Bueso, P [1 ]
Herráez, J [1 ]
Martí, JL [1 ]
Murillo, L [1 ]
Sáenz, A [1 ]
Escudero, P [1 ]
García-Prats, MD [1 ]
Tres, A [1 ]
机构：
[1] Univ Zaragoza, Div Med Oncol, Clin Hosp, Zaragoza, Spain
来源：
EUROPEAN JOURNAL OF CANCER | 1999年 / 35卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S67 / S67
页数：1
相关论文
共 50 条
  • [21] Phase I/II study of gemcitabine and cisplatin in the treatment of advanced non-small cell lung cancer: Preliminary results
    Steward, WP
    Dunlop, DJ
    Dabouis, G
    Lacroix, H
    Talbot, D
    SEMINARS IN ONCOLOGY, 1996, 23 (05) : 43 - 47
  • [22] Gemcitabine plus cisplatin versus gemcitabine plus vinorelbine in the treatment of advanced non-small cell lung cancer (NSCLC).
    Zhang, Y
    Zhang, L
    Li, N
    Xu, F
    Pan, ZK
    Guang, ZZ
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 702S - 702S
  • [23] Phase II trial of gemcitabine and cisplatin as first-line treatment of advanced non-small cell lung cancer (NSCLC).
    Lee, NS
    Byun, JH
    Bae, SB
    Kim, CK
    Lee, KT
    Park, SK
    Park, KK
    Won, JH
    Hong, DS
    Park, HS
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 701S - 701S
  • [24] A phase I dose escalation study of sunitinib in combination with gemcitabine plus cisplatin for advanced non-small cell lung cancer (NSCLC)
    Reck, M.
    Frickhofen, N.
    Gatzemeier, U.
    Fuhr, H.
    Lanzalone, S.
    Lechuga, M. J.
    Wang, E.
    Chao, R.
    Felip, E.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [25] Preliminary report an gemcitabine (G) - Ifosfamide (I) - Cisplatin (P) phase I/II trial in patients with advanced non small cell lung cancer (NSCLC)
    Bourgeois, H
    Lemerre, D
    Chicoyneau, V
    Paitry, T
    Chleze, S
    Fruge, F
    Boita, F
    Meurice, JC
    Daban, A
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S262 - S262
  • [26] Preliminary findings of a phase I dose-escalation study of sunitinib in combination with gemcitabine plus cisplatin in advanced non-small cell lung cancer (NSCLC)
    Reck, M.
    Frickhofen, N.
    Gatzemeier, U.
    Fuhr, H. G.
    Lanzalone, S.
    Wang, E.
    Chao, R.
    Felip, E.
    EJC SUPPLEMENTS, 2007, 5 (04): : 390 - 390
  • [27] High-dose gemcitabine (HDG) in non-small cell lung cancer (NSCLC)
    Munarriz, J
    Busquier, I
    López, A
    De Las Peñs, R
    Llorente, R
    Frau, A
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S263 - S263
  • [28] Phase I II study of CDDP plus vinorelbine plus gemcitabine in non-small cell lung carcinoma (NSCLC).
    Esteban, E
    Fra, J
    Puertas, J
    Sala, MA
    Carrasco, J
    Palacio, I
    Muñiz, I
    Vieitez
    Lacave, AJ
    Buesa, JM
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S62 - S62
  • [29] PHASE-II TRIAL OF ETOPOSIDE, VINCRISTINE, AND HIGH-DOSE CISPLATIN IN ADVANCED NON-SMALL CELL LUNG-CANCER
    BERTRAND, M
    MULTHAUF, P
    PRESANT, C
    RAPPAPORT, D
    BLAYNEY, DW
    CARR, BI
    CECCHI, G
    DOROSHOW, JH
    EMONT, E
    GOLDBERG, D
    KOGUT, N
    LEONG, L
    MARGOLIN, K
    CANCER TREATMENT REPORTS, 1985, 69 (11): : 1335 - 1336
  • [30] Phase I trial of gemcitabine and cisplatin in advanced non-small cell lung cancer: A preliminary report
    Shepherd, FA
    Burkes, R
    Cormier, Y
    Crump, M
    Feld, R
    Strack, T
    LUNG CANCER, 1996, 14 (01) : 135 - 144
12345